8-K: Profound Medical Sets Q4, Full Year 2025 Earnings Call

Profound Medical Corp. announced it will release its fourth quarter and full year 2025 financial results on March 5, 2026, followed by a conference call.

Summary

• Profound Medical Corp. will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026.
• A conference call to review the financial results and discuss business developments will be hosted by Profound management at 4:30 p.m. Eastern Time on the same day.
• The conference call will be broadcast live and archived on the Company's website in the Investors section.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral announcement, as it is a standard procedural update regarding the scheduling of an earnings release and conference call, providing no new financial or operational data.

Positives

• No specific positives are detailed in this announcement, as it is a procedural update regarding an upcoming financial disclosure.

Negatives

• No specific negatives are detailed in this announcement, as it is a procedural update regarding an upcoming financial disclosure.

Risks

• No specific risks are mentioned in this announcement.

Future Outlook

No forward-looking statements or guidance are provided in this announcement.

Management Comments

• No direct quotes from management regarding the results or business developments are included in this announcement, only the procedural announcement of the call.

Industry Context

StockSavvy.ai notes that Profound Medical operates in the competitive and innovation-driven interventional MRI (iMRI) medical device sector, focusing on advanced treatments for prostate disease with TULSA-PRO and various conditions with Sonalleve. The upcoming earnings call will provide crucial insights into its commercialization progress and market penetration against competitors in the minimally invasive treatment space.

Comparison to Industry Standards

• Not applicable, as this filing is an announcement of an upcoming financial report, not the report itself.

Stakeholder Impact

• Shareholders/Investors: Will receive financial results and business updates on March 5, 2026, which could influence investment decisions.
• Analysts: Will use the upcoming results and conference call for their financial models and recommendations.

Next Steps

• Release of fourth quarter and full year 2025 financial results after market close on March 5, 2026.
• Conference call to discuss financial results and business developments at 4:30 p.m. ET on March 5, 2026.

Key Dates

Keywords

Profound Medical, PROF, PRN, financial results, earnings call, Q4 2025, full year 2025, medical device, iMRI, TULSA-PRO, Sonalleve, prostate cancer, BPH, uterine fibroids